Making a Difference
When all is said and done, our customers are best qualified to describe what it is like working with Phase Forward and using our solutions. Below is a representative sampling of customer testimonials.
“Our goals were to establish a common and secure platform, develop best-in-class robust processes, be compliant with all regulations and by doing that, improve the overall quality of our studies. We have done that and more.”
Sonia Sousa
(Former) Director of the Clinical and Scientific Affairs Support Core
Philips Oral Healthcare
“We are pleased to have converted this study to EDC and are beginning to derive the benefits of InForm that we’ve found in other studies, such as greater data visibility earlier in the trials and more accurate data resulting from the edit checks that begin at the data entry stage. We also value the ability to quickly generate ad hoc reports and to quickly resolve queries. Our expectations were extremely high, but the results have measured up.”
Marina Nillni
EDC Implementation Program Manager
Dana-Farber/Harvard Cancer Center
“We share Phase Forward's dedication to drug safety. The new (Clintrace™) ECSM gateway will help us submit adverse event reports electronically with ease and at a reduced cost, and will ensure that our reports are in compliance with the FDA's latest submission standards. During our beta testing experience, these benefits were evident."
Stefano Nodari
Associate Director, Information Technology R&D
Bracco Group
“The use of these review tools resulted in less time spent by medical officers and statisticians on data management and analysis and provided more time for the interpretation of results. This strategic approach has great promise for improving the quality, speed, and transparency of the NDA safety review at FDA which can be realized through wide-scale adoption of these emerging standards at FDA."
Chuck Cooper
Medical Reviewer
U.S. Food and Drug Administration
“This innovative technology will provide valuable new tools for improving the safe use of marketed medicines. It will help us continue to strengthen processes for identifying possible risks to public health more quickly and efficiently, and will keep us at the forefront of signal detection.”
Dr. June Raine
Director of Post Licensing
U.K. Medicines and Healthcare products Regulatory Agency (MHRA)
“A key element of the success of our clinical trials concerns the speed and efficiency with which we can turn prodigious amounts of clinical trial data from individual patients into actionable industry-standard codes. In our beta testing of Central Coding for InForm, we’ve seen a substantial productivity increase in this crucial aspect of the clinical trial process. Through features and functionality that show a thorough, detailed understanding of the intricacies of this process, Central Coding for InForm can effect more efficient, more accurate and safer clinical trials.”
Selena Sibbald
Global EDC Operations Director
Quintiles Transnational Corporation
“As the leading eCRO conducting all of our trials in EDC, we realized InForm’s benefits long ago and have shared many successful implementations with Phase Forward during our strong, six-year partnership. Because of the increased efficiency it affords, we integrated InForm with our Web-based clinical trial management and reporting system (CTMS), InfoLink. By leveraging the data visibility afforded by our technology platform, combined with our high efficiency clinical processes, we’ve reduced the time from Last Patient/Last Visit to database lock to between three to eight working days. In addition to its functionality, Phase Forward’s worldwide experience will be particularly critical to PharmaLink as we anticipate future global engagements.”
Richard Staub
President and Chief Operating Officer
PharmaLinkFHI
“Phase Forward was clearly the industry leader in its field. We felt they would be around for the long run. Their system was user-friendly, and their service organization seemed strong.”
Irving Dark
VP, Business Development and Operations
Veristat Inc.
